Stuart Osborne
Basel, BS 4070, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 04, 2023
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
Journal: Journal of neuro-oncology
Published: May 10, 2018
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer.
Journal: British journal of cancer
Published: January 26, 2018
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.
Journal: Haematologica
Published: August 02, 2017
Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial.
Journal: Breast (Edinburgh, Scotland)
Published: November 24, 2016
HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: August 05, 2016
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: September 14, 2013
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.
Journal: The Lancet. Oncology
Published: August 23, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026